The higher expression of FOXP3 and CD163, specifically in the hematologic metastasis, suggests a more immunosuppressive tumor microenvironment at this stage of the disease, possibly reflecting greater infiltration of Tregs and M2-type macrophages, respectively. The gene discussed is CD163; the disease is neoplasm.